Unsuccessful in licensing talks, feds sue Gilead over PrEP-focused HIV patent

7th November 2019 Uncategorised 0

Gilead Sciences balked at licensing the U.S. government’s HIV-prevention patent rights, and now the feds are striking back. HHS sued Gilead for patent infringement Wednesday, saying the company and its HIV prophylaxis meds Truvada and Descovy reaped profits off hundreds of millions of dollars in taxpayer-funded research.

More: Unsuccessful in licensing talks, feds sue Gilead over PrEP-focused HIV patent
Source: fierce